首页 > 最新文献

Andrology最新文献

英文 中文
Gender-affirming hormone therapy: Effect on semen quality and use of fertility preservation 性别确认激素治疗:对精液质量的影响和保留生育能力的使用。
IF 3.4 2区 医学 Q1 ANDROLOGY Pub Date : 2025-08-21 DOI: 10.1111/andr.70112
Anna Chiara Conflitti, Alessandra Buonacquisto, Gaia Cicolani, Silvia Di Chiano, Marta Ruberto, Francesco Pallotti, Francesco Lombardo, Donatella Paoli

Fertility preservation (FP) is a fundamental part of gender care. Gender-affirming hormone therapy (GAHT) involves the use of drugs that could be potential risk factors for fertility. Therefore, FP is recommended before beginning the gender-affirmation process. This narrative review aims to assess several aspects, mainly concerning the assigned male at birth (AMAB) population. The purpose of this review is to provide an overview of the effects of GAHT on testicular morphology and seminal quality, the use of semen cryopreservation, the desire for parenthood among transgender people, the factors influencing the decision to use fertility preservation (FP) and suggestions for improving clinical practice. A literature search within PubMed was conducted and the results deal with issues such as changes in testicular morphology and semen quality, FP utilization, barriers to treatment, current clinical practice models, and suggestions for improving transgender adolescents access to FP. The results showed that GAHT can have a negative effect on fertility in transgender AMAB subjects. It is therefore recommended to carry out FP before starting such treatment. However, there is low percentage of utilization to FP among transgender adolescents. In deciding whether to pursue FP, they consider many factors: future parenting desires, individual experiences of gender dysphoria, family values around biological parenting, financial considerations, and the availability of fertility information. A discrepancy emerged between the rate of desire to become a parent and the actual rate of FP utilization. The reasons are various, such as cost, and concern in delaying the initiation of treatment. Suggestions for improving clinical practice are also provided from this literature search.

生育保护(FP)是性别关怀的基本组成部分。性别确认激素疗法(GAHT)涉及使用可能成为生育潜在风险因素的药物。因此,建议在开始性别确认过程之前进行计划生育。这篇叙述性综述的目的是评估几个方面,主要是关于出生时分配的男性(AMAB)人口。本文旨在综述GAHT对跨性别者睾丸形态和精液质量的影响、精液冷冻保存的使用、生育意愿、决定使用生育保存(FP)的影响因素以及改进临床实践的建议。在PubMed中进行了文献检索,结果涉及睾丸形态和精液质量的变化,计划生育的利用,治疗障碍,当前临床实践模式以及改善跨性别青少年获得计划生育的建议。结果表明,GAHT对跨性别AMAB受试者的生育能力有负面影响。因此,建议在开始这种治疗之前进行计划生育。然而,跨性别青少年使用计划生育的比例很低。在决定是否追求计划生育时,他们考虑了许多因素:未来养育子女的愿望、性别焦虑的个人经历、家庭对亲生子女的价值观、经济考虑以及生育信息的可用性。渴望成为父母的比率与计划生育的实际使用率之间出现了差异。原因是多方面的,例如费用和对延迟开始治疗的担忧。通过文献检索,提出了改进临床实践的建议。
{"title":"Gender-affirming hormone therapy: Effect on semen quality and use of fertility preservation","authors":"Anna Chiara Conflitti,&nbsp;Alessandra Buonacquisto,&nbsp;Gaia Cicolani,&nbsp;Silvia Di Chiano,&nbsp;Marta Ruberto,&nbsp;Francesco Pallotti,&nbsp;Francesco Lombardo,&nbsp;Donatella Paoli","doi":"10.1111/andr.70112","DOIUrl":"10.1111/andr.70112","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <p>Fertility preservation (FP) is a fundamental part of gender care. Gender-affirming hormone therapy (GAHT) involves the use of drugs that could be potential risk factors for fertility. Therefore, FP is recommended before beginning the gender-affirmation process. This narrative review aims to assess several aspects, mainly concerning the assigned male at birth (AMAB) population. The purpose of this review is to provide an overview of the effects of GAHT on testicular morphology and seminal quality, the use of semen cryopreservation, the desire for parenthood among transgender people, the factors influencing the decision to use fertility preservation (FP) and suggestions for improving clinical practice. A literature search within PubMed was conducted and the results deal with issues such as changes in testicular morphology and semen quality, FP utilization, barriers to treatment, current clinical practice models, and suggestions for improving transgender adolescents access to FP. The results showed that GAHT can have a negative effect on fertility in transgender AMAB subjects. It is therefore recommended to carry out FP before starting such treatment. However, there is low percentage of utilization to FP among transgender adolescents. In deciding whether to pursue FP, they consider many factors: future parenting desires, individual experiences of gender dysphoria, family values around biological parenting, financial considerations, and the availability of fertility information. A discrepancy emerged between the rate of desire to become a parent and the actual rate of FP utilization. The reasons are various, such as cost, and concern in delaying the initiation of treatment. Suggestions for improving clinical practice are also provided from this literature search.</p>\u0000 </section>\u0000 </div>","PeriodicalId":7898,"journal":{"name":"Andrology","volume":"14 1","pages":"322-330"},"PeriodicalIF":3.4,"publicationDate":"2025-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/andr.70112","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144939555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From concept to the clinic: Retinoic acid receptor α antagonist YCT-529, an oral non-hormonal male contraceptive. 从概念到临床:视黄酸受体α拮抗剂YCT-529,口服非激素男性避孕药。
IF 3.4 2区 医学 Q1 ANDROLOGY Pub Date : 2025-08-12 DOI: 10.1111/andr.70106
Noha Taher, Ehfazul Haque, Gunda I Georg

YCT-529 reversibly reduces sperm counts to infertility levels in mice and non-human primates. Mice mating studies demonstrated 99% effectiveness in preventing pregnancies. YCT-529 has completed a first-in-class, double-blind, placebo-controlled Phase I clinical safety study in men and is currently being investigated in a Phase Ib/IIa clinical study.

YCT-529可逆地将小鼠和非人类灵长类动物的精子数量减少到不育水平。老鼠交配研究表明,99%的有效性防止怀孕。YCT-529已经完成了一项同类第一、双盲、安慰剂对照的男性I期临床安全性研究,目前正在进行Ib/IIa期临床研究。
{"title":"From concept to the clinic: Retinoic acid receptor α antagonist YCT-529, an oral non-hormonal male contraceptive.","authors":"Noha Taher, Ehfazul Haque, Gunda I Georg","doi":"10.1111/andr.70106","DOIUrl":"https://doi.org/10.1111/andr.70106","url":null,"abstract":"<p><p>YCT-529 reversibly reduces sperm counts to infertility levels in mice and non-human primates. Mice mating studies demonstrated 99% effectiveness in preventing pregnancies. YCT-529 has completed a first-in-class, double-blind, placebo-controlled Phase I clinical safety study in men and is currently being investigated in a Phase Ib/IIa clinical study.</p>","PeriodicalId":7898,"journal":{"name":"Andrology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144833783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative efficacy of combination therapy including regenerative therapies versus monotherapy for erectile dysfunction: A systematic review and meta-analysis 包括再生疗法在内的联合疗法与单一疗法治疗勃起功能障碍的疗效比较:一项系统综述和荟萃分析。
IF 3.4 2区 医学 Q1 ANDROLOGY Pub Date : 2025-08-12 DOI: 10.1111/andr.70108
Alberto Quistini, Giuseppe Fallara, Marco Tozzi, Massimiliano Depalma, Rocco Damiano, Alessandro Palmieri, Fabio Castiglione, Andrea Salonia, Roberto Bianchi, Matteo Ferro, Asif Muneer, Hussain M. Alnajjar, Karl H. Pang
<div> <section> <h3> Background and objective</h3> <p>The Current European Association of Urology guidelines do not provide recommendation for combination of regenerative therapies with standard therapies for erectile dysfunction. The aim of this study was to compare the efficacy of combined regenerative therapy with monotherapy for erectile dysfunction.</p> </section> <section> <h3> Methods</h3> <p>A systematic review and meta-analysis were conducted following the 2020 Preferred Reporting Items for Systematic Reviews and Meta Analyses guidelines. The protocol was registered on PROSPERO (CRD42024522307). Randomized controlled trials and prospective/retrospective studies comparing combination therapies (low-intensity external shockwave therapy, platelet-rich plasma, stem cell therapy with phosphodiesterase-5 inhibitors, or other treatments) with monotherapy were included. Erectile function was assessed using the International Index of Erectile Function-5 and Erection Hardness Scale. Groups were compared using standardized mean difference. Subgroup analyses based on treatment type, erectile dysfunction cause, and follow-up duration were also conducted. Risk of bias was assessed using risk of bias 2 and Robins-I tools.</p> </section> <section> <h3> Key findings and limitations</h3> <p>Of 1416 articles screened, eight studies involving 553 patients met the inclusion criteria. All studies included phosphodiesterase-5 inhibitors and low-intensity external shockwave therapy as regenerative treatment, with no studies on stem cell therapy or platelet-rich plasma. After treatment, no significant difference in International Index of Erectile Function scores was found between combination and monotherapy groups. However, subgroup analysis revealed that combination therapy showed a statistically significant improvement compared to low-intensity external shockwave therapy alone (standardized mean difference: 0.61; 95% confidence interval: 0.13‒1.09; <i>p</i> = 0.013). A statistically significant improvement was found in vasculogenic (standardized mean difference: 0.65; <i>p</i> < 0.001) and diabetic cases (standardized mean difference: 1.05; <i>p</i> < 0.001).</p> </section> <section> <h3> Conclusions and clinical implications</h3> <p>Combination of phosphodiesterase-5 inhibitors and intensity external shockwave therapy resulted in significant improvement of International Index of Erectile Function compared to intensity external shockwave therapy alone. However, the risk of bias was high because of the low quality of the studies.</p> </sectio
背景和目的:目前的欧洲泌尿外科协会指南没有推荐将再生疗法与标准疗法结合起来治疗勃起功能障碍。本研究的目的是比较联合再生疗法与单一疗法治疗勃起功能障碍的疗效。方法:根据2020年系统评价和Meta分析指南首选报告项目进行系统评价和Meta分析。该协议已在PROSPERO上注册(CRD42024522307)。包括随机对照试验和前瞻性/回顾性研究,比较联合治疗(低强度外部冲击波治疗、富血小板血浆、磷酸二酯酶-5抑制剂干细胞治疗或其他治疗)与单药治疗。使用国际勃起功能指数-5和勃起硬度量表评估勃起功能。各组间比较采用标准化平均差。根据治疗类型、勃起功能障碍原因和随访时间进行亚组分析。使用偏倚风险2和罗宾斯- 1工具评估偏倚风险。主要发现和局限性:在筛选的1416篇文章中,8项涉及553例患者的研究符合纳入标准。所有的研究都包括磷酸二酯酶-5抑制剂和低强度外部冲击波治疗作为再生治疗,没有干细胞治疗或富血小板血浆的研究。治疗后,联合治疗组和单药治疗组的国际勃起功能指数评分无显著差异。然而,亚组分析显示,与单独低强度外部冲击波治疗相比,联合治疗显示出统计学上显著的改善(标准化平均差:0.61;95%置信区间:0.13-1.09;p = 0.013)。在血管源性方面有统计学上显著的改善(标准化平均差:0.65;结论及临床意义:与单独应用强外冲击波治疗相比,磷酸二酯酶-5抑制剂联合强外冲击波治疗可显著改善勃起功能国际指数。然而,由于研究质量较低,偏倚的风险很高。患者总结:磷酸二酯酶-5抑制剂联合强外冲击波治疗可显著改善勃起功能,尤其是血管源性勃起功能障碍或糖尿病患者。
{"title":"Comparative efficacy of combination therapy including regenerative therapies versus monotherapy for erectile dysfunction: A systematic review and meta-analysis","authors":"Alberto Quistini,&nbsp;Giuseppe Fallara,&nbsp;Marco Tozzi,&nbsp;Massimiliano Depalma,&nbsp;Rocco Damiano,&nbsp;Alessandro Palmieri,&nbsp;Fabio Castiglione,&nbsp;Andrea Salonia,&nbsp;Roberto Bianchi,&nbsp;Matteo Ferro,&nbsp;Asif Muneer,&nbsp;Hussain M. Alnajjar,&nbsp;Karl H. Pang","doi":"10.1111/andr.70108","DOIUrl":"10.1111/andr.70108","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Background and objective&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;The Current European Association of Urology guidelines do not provide recommendation for combination of regenerative therapies with standard therapies for erectile dysfunction. The aim of this study was to compare the efficacy of combined regenerative therapy with monotherapy for erectile dysfunction.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Methods&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;A systematic review and meta-analysis were conducted following the 2020 Preferred Reporting Items for Systematic Reviews and Meta Analyses guidelines. The protocol was registered on PROSPERO (CRD42024522307). Randomized controlled trials and prospective/retrospective studies comparing combination therapies (low-intensity external shockwave therapy, platelet-rich plasma, stem cell therapy with phosphodiesterase-5 inhibitors, or other treatments) with monotherapy were included. Erectile function was assessed using the International Index of Erectile Function-5 and Erection Hardness Scale. Groups were compared using standardized mean difference. Subgroup analyses based on treatment type, erectile dysfunction cause, and follow-up duration were also conducted. Risk of bias was assessed using risk of bias 2 and Robins-I tools.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Key findings and limitations&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Of 1416 articles screened, eight studies involving 553 patients met the inclusion criteria. All studies included phosphodiesterase-5 inhibitors and low-intensity external shockwave therapy as regenerative treatment, with no studies on stem cell therapy or platelet-rich plasma. After treatment, no significant difference in International Index of Erectile Function scores was found between combination and monotherapy groups. However, subgroup analysis revealed that combination therapy showed a statistically significant improvement compared to low-intensity external shockwave therapy alone (standardized mean difference: 0.61; 95% confidence interval: 0.13‒1.09; &lt;i&gt;p&lt;/i&gt; = 0.013). A statistically significant improvement was found in vasculogenic (standardized mean difference: 0.65; &lt;i&gt;p&lt;/i&gt; &lt; 0.001) and diabetic cases (standardized mean difference: 1.05; &lt;i&gt;p&lt;/i&gt; &lt; 0.001).&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Conclusions and clinical implications&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Combination of phosphodiesterase-5 inhibitors and intensity external shockwave therapy resulted in significant improvement of International Index of Erectile Function compared to intensity external shockwave therapy alone. However, the risk of bias was high because of the low quality of the studies.&lt;/p&gt;\u0000 &lt;/sectio","PeriodicalId":7898,"journal":{"name":"Andrology","volume":"14 2","pages":"358-367"},"PeriodicalIF":3.4,"publicationDate":"2025-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/andr.70108","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144833782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oxidative stress and testicular damage induced by chronic exposure to 35.5 GHz millimeter wave radiation in male Wistar rats 慢性35.5 GHz毫米波辐射对雄性Wistar大鼠氧化应激和睾丸损伤的影响。
IF 3.4 2区 医学 Q1 ANDROLOGY Pub Date : 2025-08-12 DOI: 10.1111/andr.70107
Rohit Gautam, Neha Jha, Anuj Kumar Tomar, Jay Prakash Nirala, Taruna Arora, Paulraj Rajamani

Background

The widespread usage of millimeter waves (MMW) in different spheres of the public domain necessitates to have a better understanding of any possible health impacts caused by them. The latest example of this is the global implementation of 5G technology.

Objectives

The present investigation aimed to study the effects of 35.5 GHz frequency on reproductive parameters of male Wistar rats.

Methods

The study employed a randomized controlled design, with animals being assigned to control, sham-exposed, and exposed groups, with six animals in each group (n = 6). The experimental group was exposed to 35.5 GHz frequency for 2 h per day for 60 days. At the end of the exposure period, various sperm parameters such as sperm count, morphology, viability, and sperm mitochondrial activity were evaluated. The evaluation of oxidative stress was done by lipid peroxidation assay in testis homogenate. Superoxide dismutase, total sulfhydryl level, and total antioxidant capacity were assessed in testis homogenate. The DNA damage in the testis was assessed through the comet assay.

Results

The results showed a significant decrease in sperm viability and count, as well as morphometric changes in testis histopathology. Lipid peroxidation testis was significantly elevated in the exposed group, while superoxide dismutase (SOD), total sulfhydryl level, and total antioxidant capacity were significantly decreased in the exposed group. The comet assay revealed a significant increase in DNA damage in the exposed group, indicating genotoxic effects.

Discussion

The observed changes in sperm parameters, testicular morphology, and oxidative stress markers highlight the potential for testicular tissue damage via oxidative mechanisms. These results underscore the need for further research to elucidate the biological implications of chronic MMW exposure.

Conclusion

Chronic exposure to 35.5 GHz frequency may negatively impact male reproductive function and testicular tissue, primarily through mechanisms involving oxidative stress.

背景:由于毫米波在公共领域不同领域的广泛使用,有必要更好地了解它们可能对健康造成的任何影响。最新的例子是5G技术的全球实施。目的:研究35.5 GHz频率对雄性Wistar大鼠生殖参数的影响。方法:采用随机对照设计,将动物分为对照组、假暴露组和暴露组,每组6只(n = 6)。试验组连续60天,每天暴露在35.5 GHz频率下2小时。在暴露期结束时,评估各种精子参数,如精子数量、形态、活力和精子线粒体活性。用睾丸匀浆脂质过氧化法评价氧化应激。测定睾丸匀浆中超氧化物歧化酶、总巯基水平和总抗氧化能力。通过彗星试验评估睾丸中的DNA损伤。结果:结果显示精子活力和数量明显下降,睾丸组织病理学形态学改变。暴露组睾丸脂质过氧化水平显著升高,超氧化物歧化酶(SOD)、总巯基水平和总抗氧化能力显著降低。彗星试验显示,暴露组的DNA损伤显著增加,表明基因毒性作用。讨论:观察到的精子参数、睾丸形态和氧化应激标志物的变化强调了通过氧化机制导致睾丸组织损伤的可能性。这些结果强调需要进一步研究以阐明慢性毫米波暴露的生物学意义。结论:长期暴露于35.5 GHz频率可能对男性生殖功能和睾丸组织产生负面影响,主要是通过氧化应激机制。
{"title":"Oxidative stress and testicular damage induced by chronic exposure to 35.5 GHz millimeter wave radiation in male Wistar rats","authors":"Rohit Gautam,&nbsp;Neha Jha,&nbsp;Anuj Kumar Tomar,&nbsp;Jay Prakash Nirala,&nbsp;Taruna Arora,&nbsp;Paulraj Rajamani","doi":"10.1111/andr.70107","DOIUrl":"10.1111/andr.70107","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>The widespread usage of millimeter waves (MMW) in different spheres of the public domain necessitates to have a better understanding of any possible health impacts caused by them. The latest example of this is the global implementation of 5G technology.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>The present investigation aimed to study the effects of 35.5 GHz frequency on reproductive parameters of male Wistar rats.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The study employed a randomized controlled design, with animals being assigned to control, sham-exposed, and exposed groups, with six animals in each group (<i>n</i> = 6). The experimental group was exposed to 35.5 GHz frequency for 2 h per day for 60 days. At the end of the exposure period, various sperm parameters such as sperm count, morphology, viability, and sperm mitochondrial activity were evaluated. The evaluation of oxidative stress was done by lipid peroxidation assay in testis homogenate. Superoxide dismutase, total sulfhydryl level, and total antioxidant capacity were assessed in testis homogenate. The DNA damage in the testis was assessed through the comet assay.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The results showed a significant decrease in sperm viability and count, as well as morphometric changes in testis histopathology. Lipid peroxidation testis was significantly elevated in the exposed group, while superoxide dismutase (SOD), total sulfhydryl level, and total antioxidant capacity were significantly decreased in the exposed group. The comet assay revealed a significant increase in DNA damage in the exposed group, indicating genotoxic effects.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion</h3>\u0000 \u0000 <p>The observed changes in sperm parameters, testicular morphology, and oxidative stress markers highlight the potential for testicular tissue damage via oxidative mechanisms. These results underscore the need for further research to elucidate the biological implications of chronic MMW exposure.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Chronic exposure to 35.5 GHz frequency may negatively impact male reproductive function and testicular tissue, primarily through mechanisms involving oxidative stress.</p>\u0000 </section>\u0000 </div>","PeriodicalId":7898,"journal":{"name":"Andrology","volume":"14 2","pages":"594-602"},"PeriodicalIF":3.4,"publicationDate":"2025-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144833784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The aporetic dialogs of Modena on gender differences: Is it all about testosterone? Episode III: Mathematics 摩德纳关于性别差异的悲叹对话:这一切都与睾丸激素有关吗?第三集:数学。
IF 3.4 2区 医学 Q1 ANDROLOGY Pub Date : 2025-07-28 DOI: 10.1111/andr.70104
Giulia Brigante, Francesco Costantino, Alessio Bellelli, Stefano Boni, Chiara Furini, Rita Cucchiara, Manuela Simoni

This report is the transcript of what was discussed in a convention at the Endocrinology Unit in Modena, Italy, in the form of the aporetic dialogs of ancient Greece. It is the third episode of a series of four discussions on the differences between males and females, with a multidisciplinary approach. In this work, the role of testosterone in gender differences in the aptitude for mathematics is explored. First, the definitions of mathematical abilities were provided together with any gender difference in the distribution of females and males in science, technology, engineering, and mathematics subjects. A clear predominance of males is evident at most science, technology, engineering, and mathematics education levels, especially in advanced academic careers. Then, the discussants were divided into two groups: group 1, which illustrated the thesis that testosterone promotes the development of logical‒mathematical skills, and group 2, which, in contrast, asserted the inconsistency of a direct role of testosterone in improving cognitive abilities and that socio-cultural factors should be considered on the basis of this gender gap. In the end, an expert referee (a female engineer) tried to resolve the aporia: are the two theories equivalent or is one superior?

这篇报道是在意大利摩德纳内分泌科的一次会议上以古希腊对话的形式讨论的内容的文字记录。这是一系列关于男女差异的四次讨论的第三集,采用多学科方法。在这项工作中,睾酮在数学能力的性别差异中的作用进行了探讨。首先,提供了数学能力的定义,以及在科学、技术、工程和数学学科中男女分布的性别差异。在大多数科学、技术、工程和数学教育水平上,尤其是在高等学术生涯中,男性明显占主导地位。然后,讨论者被分成两组:第一组,阐述了睾丸激素促进逻辑数学技能发展的论点;第二组,相反,断言睾丸激素在提高认知能力方面的直接作用是不一致的,应该在这种性别差距的基础上考虑社会文化因素。最后,一位专家裁判(一位女工程师)试图解决这个困惑:这两种理论是等同的,还是一种更优越?
{"title":"The aporetic dialogs of Modena on gender differences: Is it all about testosterone? Episode III: Mathematics","authors":"Giulia Brigante,&nbsp;Francesco Costantino,&nbsp;Alessio Bellelli,&nbsp;Stefano Boni,&nbsp;Chiara Furini,&nbsp;Rita Cucchiara,&nbsp;Manuela Simoni","doi":"10.1111/andr.70104","DOIUrl":"10.1111/andr.70104","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <p>This report is the transcript of what was discussed in a convention at the Endocrinology Unit in Modena, Italy, in the form of the aporetic dialogs of ancient Greece. It is the third episode of a series of four discussions on the differences between males and females, with a multidisciplinary approach. In this work, the role of testosterone in gender differences in the aptitude for mathematics is explored. First, the definitions of mathematical abilities were provided together with any gender difference in the distribution of females and males in science, technology, engineering, and mathematics subjects. A clear predominance of males is evident at most science, technology, engineering, and mathematics education levels, especially in advanced academic careers. Then, the discussants were divided into two groups: group 1, which illustrated the thesis that testosterone promotes the development of logical‒mathematical skills, and group 2, which, in contrast, asserted the inconsistency of a direct role of testosterone in improving cognitive abilities and that socio-cultural factors should be considered on the basis of this gender gap. In the end, an expert referee (a female engineer) tried to resolve the aporia: are the two theories equivalent or is one superior?</p>\u0000 </section>\u0000 </div>","PeriodicalId":7898,"journal":{"name":"Andrology","volume":"14 2","pages":"335-344"},"PeriodicalIF":3.4,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/andr.70104","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144726586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spatial transcriptomics mapping of immune cell and TGFβ signalling pathway heterogeneity in testicular germ cell tumours 睾丸生殖细胞肿瘤中免疫细胞和tgf - β信号通路异质性的空间转录组学定位
IF 3.4 2区 医学 Q1 ANDROLOGY Pub Date : 2025-07-22 DOI: 10.1111/andr.70100
Sarah C. Moody, Daniela Fietz, Benedict Nathaniel, Mark Frydenberg, Ben Tran, Hans-Christian Schuppe, Kate L. Loveland

Background

Testicular germ cell tumours (TGCTs) are amongst the most common malignancies in young men, and their incidence is increasing worldwide. Tissue heterogeneity hampers efforts to understand how TGCT precursors (termed germ cell neoplasia in situ; GCNIS) emerge and progress, restricting elucidation of new strategies for diagnosis and management.

Objectives

This study reports the use of spatial transcriptomic analysis in TGCT tissue sections.

Materials and methods

Over 90 regions of interest (ROIs) were identified in sections from four TGCT patients’ samples, three with non-seminoma, one seminoma. Transcripts in each ROI were sequenced and examined using the NanoString GeoMx spatial whole transcriptomics workflow, the values normalised and analysed using Degust RNA-Seq and Ingenuity Pathway Analysis software.

Results

The distribution and expression of functional markers in specific cell types was used to map individual tumours, GCNIS, and tumour-adjacent regions. Significant heterogeneity in TGCTs and surrounding areas is documented between patients and across different regions in the same tumour. Immune cell-related transcripts encoding macrophage, T cell, B cell, natural killer cell, dendritic cells and neutrophil subsets were identified as contributing substantially to tumour heterogeneity. Assessment of ROIs containing GCNIS and areas immediately adjacent from two individual non-seminoma tumour samples identified the TGFβ family as contributing to upstream regulation of transcripts in both patients; known activin A target genes were differentially expressed between the GCNIS and microenvironment ROIs. In addition, two discrete tumour areas within the seminoma sample displayed distinct transcript profiles, one featuring higher levels of immune cell-related transcripts, and the other TGFβ superfamily transcripts.

Conclusion

These findings highlight aspects of the complex challenge faced while seeking therapeutic targets to enable tumour spread restriction. However, these outcomes reinforce knowledge that TGFβ family members can influence seminoma fate and provide new evidence of their potential contribution to the transition of GCNIS cells into tumours.

背景:睾丸生殖细胞肿瘤(tgct)是年轻男性中最常见的恶性肿瘤之一,其发病率在世界范围内呈上升趋势。组织异质性阻碍了人们理解TGCT前体(称为原位生殖细胞瘤;GCNIS的出现和发展,限制了新的诊断和管理策略的阐明。目的:本研究报道了TGCT组织切片空间转录组学分析的应用。材料和方法:在4例TGCT患者样本的切片中鉴定出90多个感兴趣区域(roi),其中3例为非精原细胞瘤,1例为精原细胞瘤。使用NanoString GeoMx空间全转录组工作流程对每个ROI中的转录本进行测序和检查,使用Degust RNA-Seq和Ingenuity Pathway Analysis软件对值进行归一化和分析。结果:功能标记物在特定细胞类型中的分布和表达可用于绘制单个肿瘤、GCNIS和肿瘤邻近区域。tgct和周围区域在患者之间以及同一肿瘤的不同区域具有显著的异质性。编码巨噬细胞、T细胞、B细胞、自然杀伤细胞、树突状细胞和中性粒细胞亚群的免疫细胞相关转录本被认为是导致肿瘤异质性的重要因素。对含有GCNIS的roi和两个非精原细胞瘤样本相邻区域的评估发现,TGFβ家族在这两个患者中都有助于转录物的上游调控;已知的激活素A靶基因在GCNIS和微环境roi之间存在差异表达。此外,精原细胞瘤样本中的两个离散肿瘤区域显示出不同的转录谱,一个具有更高水平的免疫细胞相关转录物,另一个具有TGFβ超家族转录物。结论:这些发现突出了在寻求抑制肿瘤扩散的治疗靶点时所面临的复杂挑战。然而,这些结果强化了TGFβ家族成员可以影响精原细胞瘤命运的认识,并提供了它们对GCNIS细胞向肿瘤转变的潜在贡献的新证据。
{"title":"Spatial transcriptomics mapping of immune cell and TGFβ signalling pathway heterogeneity in testicular germ cell tumours","authors":"Sarah C. Moody,&nbsp;Daniela Fietz,&nbsp;Benedict Nathaniel,&nbsp;Mark Frydenberg,&nbsp;Ben Tran,&nbsp;Hans-Christian Schuppe,&nbsp;Kate L. Loveland","doi":"10.1111/andr.70100","DOIUrl":"10.1111/andr.70100","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Testicular germ cell tumours (TGCTs) are amongst the most common malignancies in young men, and their incidence is increasing worldwide. Tissue heterogeneity hampers efforts to understand how TGCT precursors (termed germ cell neoplasia in situ; GCNIS) emerge and progress, restricting elucidation of new strategies for diagnosis and management.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>This study reports the use of spatial transcriptomic analysis in TGCT tissue sections.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Materials and methods</h3>\u0000 \u0000 <p>Over 90 regions of interest (ROIs) were identified in sections from four TGCT patients’ samples, three with non-seminoma, one seminoma. Transcripts in each ROI were sequenced and examined using the NanoString GeoMx spatial whole transcriptomics workflow, the values normalised and analysed using Degust RNA-Seq and Ingenuity Pathway Analysis software.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The distribution and expression of functional markers in specific cell types was used to map individual tumours, GCNIS, and tumour-adjacent regions. Significant heterogeneity in TGCTs and surrounding areas is documented between patients and across different regions in the same tumour. Immune cell-related transcripts encoding macrophage, T cell, B cell, natural killer cell, dendritic cells and neutrophil subsets were identified as contributing substantially to tumour heterogeneity. Assessment of ROIs containing GCNIS and areas immediately adjacent from two individual non-seminoma tumour samples identified the TGFβ family as contributing to upstream regulation of transcripts in both patients; known activin A target genes were differentially expressed between the GCNIS and microenvironment ROIs. In addition, two discrete tumour areas within the seminoma sample displayed distinct transcript profiles, one featuring higher levels of immune cell-related transcripts, and the other TGFβ superfamily transcripts.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>These findings highlight aspects of the complex challenge faced while seeking therapeutic targets to enable tumour spread restriction. However, these outcomes reinforce knowledge that TGFβ family members can influence seminoma fate and provide new evidence of their potential contribution to the transition of GCNIS cells into tumours.</p>\u0000 </section>\u0000 </div>","PeriodicalId":7898,"journal":{"name":"Andrology","volume":"14 1","pages":"210-227"},"PeriodicalIF":3.4,"publicationDate":"2025-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/andr.70100","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144681900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Uncovering novel therapeutic targets for premature ejaculation from gut microbiota: A prospective high-throughput sequencing study. 从肠道微生物群中发现早泄的新治疗靶点:一项前瞻性高通量测序研究。
IF 3.2 2区 医学 Q1 ANDROLOGY Pub Date : 2025-07-22 DOI: 10.1111/andr.70099
Guangdong Hou, Geng Zhang, Yu Zheng, Siyan Zhang, Massimo Federici, Ping Meng, Fuli Wang, Bo Zhang, Emmanuele A Jannini, Jianlin Yuan

Background: Despite being the only approved oral therapy for premature ejaculation (PE), dapoxetine faces high discontinuation rates because of its suboptimal efficacy. Given that the role of gut microbiota in PE treatment has remained unexplored, we aim to investigate gut microbiota that may reflect the efficacy of dapoxetine.

Methods: Clinical data and fecal samples were collected from patients with lifelong PE before treatment. Gut microbiota was profiled via 16S rDNA sequencing, and differential microbiota between effective and ineffective groups were identified with the LEfSe method. To explore potential links between gut dysbiosis and efficacy, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway functional predictions were performed with the PICRUSt2 method. Efficacy was assessed using the Clinical Global Impression of Change (CGIC) scale, with scores ≥1 defined as the effective group.

Results: In the effective group, Erysipelotrichaceae_UCG_003, Parabacteroides_distasonis, and Prevotella_7_unclassified were significantly more prevalent, while Collinsella aerofaciens was less abundant. Their abundance was significantly correlated with CGIC scores, with correlation coefficients of 0.331, 0.250, 0.288, and ‒0.345, respectively. The discriminatory abilities of the four differential microbiota were 0.654, 0.669, 0.701, and 0.615, respectively. Incorporating them significantly improved the accuracy of the model predicting efficacy (0.796 vs. 0.738), which further suggests that modulating microbiota could be a novel strategy for PE treatment. The predicted gene abundance in the arachidonic acid metabolism pathway was significantly elevated in the effective group, indicating that dapoxetine's mechanism may also involve modulating this pathway.

Conclusions: This study identified gut microbiota associated with the efficacy of dapoxetine for the first time. Targeted modulation of specific gut microbiota may provide a novel strategy for PE treatment.

背景:尽管达泊西汀是唯一被批准用于早泄(PE)的口服治疗药物,但由于其疗效欠佳,达泊西汀面临着很高的停药率。鉴于肠道微生物群在PE治疗中的作用尚未被探索,我们的目标是研究可能反映达泊西汀疗效的肠道微生物群。方法:收集终身PE患者治疗前的临床资料及粪便标本。通过16S rDNA测序分析肠道菌群,并通过LEfSe方法鉴定有效组和无效组之间的差异菌群。为了探索肠道生态失调与疗效之间的潜在联系,使用PICRUSt2方法进行了京都基因与基因组百科全书(KEGG)途径功能预测。采用临床总体改变印象(CGIC)量表评估疗效,得分≥1为有效组。结果:有效组丹毒、副杆菌、非分类普雷沃菌数量显著增加,而气法Collinsella较少。它们的丰度与CGIC评分呈显著相关,相关系数分别为0.331、0.250、0.288和-0.345。4个差异菌群的区分能力分别为0.654、0.669、0.701和0.615。纳入它们显著提高了模型预测疗效的准确性(0.796比0.738),这进一步表明调节微生物群可能是PE治疗的一种新策略。有效组花生四烯酸代谢通路预测基因丰度显著升高,提示达泊西汀的作用机制也可能与调节该通路有关。结论:本研究首次确定了与达泊西汀疗效相关的肠道微生物群。针对性地调节特定的肠道微生物群可能为PE的治疗提供一种新的策略。
{"title":"Uncovering novel therapeutic targets for premature ejaculation from gut microbiota: A prospective high-throughput sequencing study.","authors":"Guangdong Hou, Geng Zhang, Yu Zheng, Siyan Zhang, Massimo Federici, Ping Meng, Fuli Wang, Bo Zhang, Emmanuele A Jannini, Jianlin Yuan","doi":"10.1111/andr.70099","DOIUrl":"https://doi.org/10.1111/andr.70099","url":null,"abstract":"<p><strong>Background: </strong>Despite being the only approved oral therapy for premature ejaculation (PE), dapoxetine faces high discontinuation rates because of its suboptimal efficacy. Given that the role of gut microbiota in PE treatment has remained unexplored, we aim to investigate gut microbiota that may reflect the efficacy of dapoxetine.</p><p><strong>Methods: </strong>Clinical data and fecal samples were collected from patients with lifelong PE before treatment. Gut microbiota was profiled via 16S rDNA sequencing, and differential microbiota between effective and ineffective groups were identified with the LEfSe method. To explore potential links between gut dysbiosis and efficacy, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway functional predictions were performed with the PICRUSt2 method. Efficacy was assessed using the Clinical Global Impression of Change (CGIC) scale, with scores ≥1 defined as the effective group.</p><p><strong>Results: </strong>In the effective group, Erysipelotrichaceae_UCG_003, Parabacteroides_distasonis, and Prevotella_7_unclassified were significantly more prevalent, while Collinsella aerofaciens was less abundant. Their abundance was significantly correlated with CGIC scores, with correlation coefficients of 0.331, 0.250, 0.288, and ‒0.345, respectively. The discriminatory abilities of the four differential microbiota were 0.654, 0.669, 0.701, and 0.615, respectively. Incorporating them significantly improved the accuracy of the model predicting efficacy (0.796 vs. 0.738), which further suggests that modulating microbiota could be a novel strategy for PE treatment. The predicted gene abundance in the arachidonic acid metabolism pathway was significantly elevated in the effective group, indicating that dapoxetine's mechanism may also involve modulating this pathway.</p><p><strong>Conclusions: </strong>This study identified gut microbiota associated with the efficacy of dapoxetine for the first time. Targeted modulation of specific gut microbiota may provide a novel strategy for PE treatment.</p>","PeriodicalId":7898,"journal":{"name":"Andrology","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2025-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144681901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brain structural and functional differences in anejaculation and sleep disorders: A functional magnetic resonance imaging-based approach 射精和睡眠障碍的脑结构和功能差异:一种基于功能磁共振成像的方法。
IF 3.4 2区 医学 Q1 ANDROLOGY Pub Date : 2025-07-15 DOI: 10.1111/andr.70095
Qiushi Liu, Ming Wang, Dangwei Peng, Zihang Chen, Juncheng Ma, Jinying Yang, Tommaso B. Jannini, Emmanuele A. Jannini, Ci Zou, Hui Jiang, Xiansheng Zhang

Background and aims

Sleep disorders (SDs) have been identified as an independent risk factor for ejaculatory dysfunctions; yet the neurophysiological mechanisms underlying the comorbidity between anejaculation (AE) and SDs remain poorly understood. This study aims to investigate the potential pathways that connect SDs and AE, comparing findings across a sample of affected patients and healthy controls (HCs) to better elucidate these complex interactions.

Methods

Resting-state functional magnetic resonance imaging (rs-fMRI) data were obtained for 21 AE patients, 20 patients with anejaculation accompanied by sleep disorders (AESD), and 18 HCs. We analyzed group differences in fractional amplitude of low-frequency fluctuations (fALFF), regional homogeneity (ReHo), voxel-based morphometry (VBM), and functional connectivity (FC) values between brain regions of interest (ROIs).

Results

FALFF significant differences were seen in the medial superior frontal gyrus as well as in the left middle occipital gyrus. ReHo analysis demonstrated significant differences among groups in the left middle occipital gyrus, left superior parietal lobe, and left middle temporal gyrus. Different cerebellar area 7b volumes in the AE group compared to the other groups were also reported. Additionally, the AESDs group demonstrated different FC signals in multiple brain areas compared to the other groups.

Conclusion

Rs-fMRI reported structural and functional differences in the brain activity across three groups. This study was the first to disentangle potential links between sleep disorders and AE, generating insights that may guide future therapeutic approaches.

背景和目的:睡眠障碍(SDs)已被确定为射精功能障碍的独立危险因素;然而,射精和SDs合并症的神经生理机制尚不清楚。本研究旨在探讨SDs和AE之间的潜在联系途径,比较受影响患者和健康对照(hc)样本的结果,以更好地阐明这些复杂的相互作用。方法:对21例AE患者、20例射精伴睡眠障碍(AESD)患者和18例hc患者进行静息状态功能磁共振成像(rs-fMRI)数据分析。我们分析了各组低频波动分数幅度(fALFF)、区域均匀性(ReHo)、基于体素的形态测量(VBM)和大脑感兴趣区域(roi)之间的功能连接(FC)值的差异。结果:在额上内侧回和左枕中回中有显著性差异。ReHo分析显示,各组间左枕中回、左顶叶上叶和左颞中回有显著性差异。我们还报道了AE组与其他组相比小脑面积7b的差异。此外,与其他组相比,aesd组在多个脑区显示出不同的FC信号。结论:Rs-fMRI报告了三组大脑活动的结构和功能差异。这项研究首次揭示了睡眠障碍和AE之间的潜在联系,为未来的治疗方法提供了指导。
{"title":"Brain structural and functional differences in anejaculation and sleep disorders: A functional magnetic resonance imaging-based approach","authors":"Qiushi Liu,&nbsp;Ming Wang,&nbsp;Dangwei Peng,&nbsp;Zihang Chen,&nbsp;Juncheng Ma,&nbsp;Jinying Yang,&nbsp;Tommaso B. Jannini,&nbsp;Emmanuele A. Jannini,&nbsp;Ci Zou,&nbsp;Hui Jiang,&nbsp;Xiansheng Zhang","doi":"10.1111/andr.70095","DOIUrl":"10.1111/andr.70095","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background and aims</h3>\u0000 \u0000 <p>Sleep disorders (SDs) have been identified as an independent risk factor for ejaculatory dysfunctions; yet the neurophysiological mechanisms underlying the comorbidity between anejaculation (AE) and SDs remain poorly understood. This study aims to investigate the potential pathways that connect SDs and AE, comparing findings across a sample of affected patients and healthy controls (HCs) to better elucidate these complex interactions.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Resting-state functional magnetic resonance imaging (rs-fMRI) data were obtained for 21 AE patients, 20 patients with anejaculation accompanied by sleep disorders (AESD), and 18 HCs. We analyzed group differences in fractional amplitude of low-frequency fluctuations (fALFF), regional homogeneity (ReHo), voxel-based morphometry (VBM), and functional connectivity (FC) values between brain regions of interest (ROIs).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>FALFF significant differences were seen in the medial superior frontal gyrus as well as in the left middle occipital gyrus. ReHo analysis demonstrated significant differences among groups in the left middle occipital gyrus, left superior parietal lobe, and left middle temporal gyrus. Different cerebellar area 7b volumes in the AE group compared to the other groups were also reported. Additionally, the AESDs group demonstrated different FC signals in multiple brain areas compared to the other groups.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Rs-fMRI reported structural and functional differences in the brain activity across three groups. This study was the first to disentangle potential links between sleep disorders and AE, generating insights that may guide future therapeutic approaches.</p>\u0000 </section>\u0000 </div>","PeriodicalId":7898,"journal":{"name":"Andrology","volume":"14 2","pages":"368-376"},"PeriodicalIF":3.4,"publicationDate":"2025-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144635939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Testicular vasal diameter: A new intra-operative predictor of vasectomy reversal success? 睾丸输精管直径:输精管切除术逆转成功的一个新的术中预测指标?
IF 3.4 2区 医学 Q1 ANDROLOGY Pub Date : 2025-07-11 DOI: 10.1111/andr.70098
Trevor J. Maloney, Daniel B. Armstrong, Loran J. Grant, Gartrell C. Bowling, Michael Zamani, Nora Watson, Robert C. Dean, Dorota J. Hawksworth
<div> <section> <h3> Background</h3> <p>Vasectomy reversal (VR) can be a challenging surgery and numerous factors have been identified to guide surgical decision-making to optimize success.</p> </section> <section> <h3> Objectives</h3> <p>The objective of this study was to identify pre-operative and intra-operative factors associated with VR surgical method and success. Additionally, we aimed to investigate the role of testicular vas deferens diameter in surgical decision-making and success.</p> </section> <section> <h3> Materials and methods</h3> <p>This study was a retrospective cohort of men >18 years of age who underwent a VR at our Institution from January 2008 to June 2023. Qualified patients underwent chart review and details recorded included age, obstructive interval, surgical technique, vasal lumen diameters, presence of sperm granuloma or surgical clips, sperm quality, and vasal fluid quality. Semen analysis (SA) parameters were also recorded. Pregnancy outcomes were ascertained via telephone interview. Descriptive statistics and correlations were analyzed with two-sample <i>t</i>-tests for continuous and chi-square or Fisher's exact tests for categorical characteristics. Logistic regression using generalized estimating equation (GEE) methods was used to estimate associations of diameter with surgery types unadjusted and adjusted for patient and intra-operative fluid characteristics.</p> </section> <section> <h3> Results</h3> <p>A total of 710 patients underwent VR during the study period and 326 post-operative semen analyses were available for review. Average patient was 38 years old, with an obstructive interval of 10 years. Vasoepididymostomy (VE) had modestly larger observed mean testicular vasal lumen diameter (0.94 mm) versus vasovasostomy (VV; 0.88 mm; <i>p</i> = 0.10). However, diameter ≥1 mm was associated with >2 times higher odds of VE versus VV (odds ratio [OR] 2.12; <i>p</i> < 0.01) adjusted for several patient characteristics. VE was associated with lower frequency of positive post-operative semen analyses (64.4% VV/VE or bilateral VE vs. 92.4% bilateral VV), and longer obstructive interval (11.5 years VV/VE or bilateral VE vs. 7.84 years bilateral VV). There were higher rates of spermatozoa on post-operative SAs when bilateral VV was performed (VV/VV 92.3%; VV/VE 73.3%; VE/VE 51.5%; <i>p</i> < 0.001). Of the 207 patients with pregnancy data, 103 (49.8%) experienced pregnancy following VR.</p> </section> <section> <h3> Discussion and conclusion</h3> <p>Intra-operative measurements of testicular vasal lumen diameter
背景:输精管切除术逆转(VR)是一项具有挑战性的手术,许多因素已经确定,以指导手术决策,以优化成功。目的:本研究的目的是确定与VR手术方法和成功相关的术前和术中因素。此外,我们旨在探讨睾丸输精管直径在手术决策和成功中的作用。材料和方法:本研究是一项回顾性队列研究,研究对象为2008年1月至2023年6月期间在我院接受VR手术的18岁男性。对符合条件的患者进行图表回顾,详细记录包括年龄、梗阻时间、手术技术、血管管腔直径、精子肉芽肿或手术夹的存在、精子质量和血管液体质量。同时记录精液分析(SA)参数。通过电话访谈确定妊娠结局。描述性统计和相关性分析采用两样本连续t检验和卡方检验或Fisher精确检验进行分类特征。采用广义估计方程(GEE)方法进行Logistic回归,估计直径与手术类型的关联,未调整和调整了患者和术中液体特征。结果:共有710例患者在研究期间接受了VR, 326例术后精液分析可用于回顾。患者平均年龄38岁,梗阻期为10年。血管附睾吻合术(VE)的平均睾丸血管管腔直径(0.94 mm)比血管吻合术(VV;0.88毫米;p = 0.10)。然而,直径≥1 mm与>相关的VE比VV的几率高2倍(优势比[OR] 2.12;p讨论与结论:术中测量睾丸血管管腔直径是影响VR技术选择的辅助因素。这一发现有助于指导术前手术咨询和VR成功率。
{"title":"Testicular vasal diameter: A new intra-operative predictor of vasectomy reversal success?","authors":"Trevor J. Maloney,&nbsp;Daniel B. Armstrong,&nbsp;Loran J. Grant,&nbsp;Gartrell C. Bowling,&nbsp;Michael Zamani,&nbsp;Nora Watson,&nbsp;Robert C. Dean,&nbsp;Dorota J. Hawksworth","doi":"10.1111/andr.70098","DOIUrl":"10.1111/andr.70098","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Background&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Vasectomy reversal (VR) can be a challenging surgery and numerous factors have been identified to guide surgical decision-making to optimize success.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Objectives&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;The objective of this study was to identify pre-operative and intra-operative factors associated with VR surgical method and success. Additionally, we aimed to investigate the role of testicular vas deferens diameter in surgical decision-making and success.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Materials and methods&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;This study was a retrospective cohort of men &gt;18 years of age who underwent a VR at our Institution from January 2008 to June 2023. Qualified patients underwent chart review and details recorded included age, obstructive interval, surgical technique, vasal lumen diameters, presence of sperm granuloma or surgical clips, sperm quality, and vasal fluid quality. Semen analysis (SA) parameters were also recorded. Pregnancy outcomes were ascertained via telephone interview. Descriptive statistics and correlations were analyzed with two-sample &lt;i&gt;t&lt;/i&gt;-tests for continuous and chi-square or Fisher's exact tests for categorical characteristics. Logistic regression using generalized estimating equation (GEE) methods was used to estimate associations of diameter with surgery types unadjusted and adjusted for patient and intra-operative fluid characteristics.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Results&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;A total of 710 patients underwent VR during the study period and 326 post-operative semen analyses were available for review. Average patient was 38 years old, with an obstructive interval of 10 years. Vasoepididymostomy (VE) had modestly larger observed mean testicular vasal lumen diameter (0.94 mm) versus vasovasostomy (VV; 0.88 mm; &lt;i&gt;p&lt;/i&gt; = 0.10). However, diameter ≥1 mm was associated with &gt;2 times higher odds of VE versus VV (odds ratio [OR] 2.12; &lt;i&gt;p&lt;/i&gt; &lt; 0.01) adjusted for several patient characteristics. VE was associated with lower frequency of positive post-operative semen analyses (64.4% VV/VE or bilateral VE vs. 92.4% bilateral VV), and longer obstructive interval (11.5 years VV/VE or bilateral VE vs. 7.84 years bilateral VV). There were higher rates of spermatozoa on post-operative SAs when bilateral VV was performed (VV/VV 92.3%; VV/VE 73.3%; VE/VE 51.5%; &lt;i&gt;p&lt;/i&gt; &lt; 0.001). Of the 207 patients with pregnancy data, 103 (49.8%) experienced pregnancy following VR.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Discussion and conclusion&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Intra-operative measurements of testicular vasal lumen diameter","PeriodicalId":7898,"journal":{"name":"Andrology","volume":"14 2","pages":"480-486"},"PeriodicalIF":3.4,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144607205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A prospective study of semen quality and fecundability among North American couples planning pregnancy 北美计划怀孕夫妇精液质量和生育能力的前瞻性研究。
IF 3.4 2区 医学 Q1 ANDROLOGY Pub Date : 2025-07-11 DOI: 10.1111/andr.70084
Sharonda M. Lovett, Greg J. Sommer, Dmitrii Krivorotko, Amelia K. Wesselink, Kenneth J. Rothman, Elizabeth E. Hatch, Michael L. Eisenberg, Lauren A. Wise
<div> <section> <h3> Background</h3> <p>Few studies have prospectively evaluated semen quality (using the most up-to-date clinically relevant definitions) and fecundability (the per-cycle probability of conception).</p> </section> <section> <h3> Objective</h3> <p>To study semen quality in relation to fecundability.</p> </section> <section> <h3> Materials and methods</h3> <p>We analyzed prospectively collected data from 763 male participants aged ≥21 years from Pregnancy Study Online (PRESTO), a North American preconception cohort study (2015–2024). Eligible participants for the semen testing substudy resided in the contiguous United States, had been attempting conception for ≤6 cycles at cohort entry, and had a female partner aged 21–45 years with regular menses. Participants used an at-home semen testing device to measure semen volume, sperm concentration, and motile sperm concentration. Participants contributed up to two semen tests during the preconception period (1376 total semen samples). We calculated sperm motility, total sperm count, and total motile sperm count. We evaluated results according to 2021 World Health Organization (WHO)-defined thresholds for low semen quality. Female participants reported their pregnancy status on bimonthly follow-up questionnaires for up to 12 cycles or until conception, whichever came first. We used proportional probabilities regression models to estimate fecundability ratios (FRs) and 95% confidence intervals (CIs), adjusting for potential confounders.</p> </section> <section> <h3> Results</h3> <p>After accounting for censoring using life-table methods, 80.7% of couples conceived within 12 cycles. FRs were 1.48 (95% CI, 1.05–2.08) for low semen volume (≤1.5 vs. >1.5 mL), 0.74 (95% CI, 0.56–0.97) for low sperm concentration (≤16 vs. >16 million/mL), 0.98 (95% CI, 0.81–1.19) for low sperm motility (≤42 vs. >42%), 0.58 (95% CI, 0.38–0.88) for low total sperm count (≤39 vs. >39 million), and 0.73 (95% CI, 0.52–1.04) for low total motile sperm count (≤21 vs. >21 million). Associations between low total motile sperm count and fecundability were stronger among couples with <3 cycles of attempt time at cohort entry.</p> </section> <section> <h3> Discussion</h3> <p>In this prospective preconception cohort study of North American couples, most suboptimal semen parameters based on WHO criteria were associated with reduced fecundability, with the exception of low semen volume.</p> </section> <section> <h3> Conclusion</h3> <p
背景:很少有研究前瞻性地评估精液质量(使用最新的临床相关定义)和生育能力(每个周期受孕概率)。目的:探讨精液质量与生殖力的关系。材料和方法:我们前瞻性地收集了北美孕前队列研究(2015-2024)中763名年龄≥21岁的男性参与者的数据。符合条件的精液检测子研究参与者居住在美国邻近地区,在队列进入时已经尝试怀孕≤6个周期,并且有一个年龄在21-45岁的月经规律的女性伴侣。参与者使用家庭精液检测设备来测量精液量、精子浓度和活动精子浓度。参与者在孕前期间提供了多达两次精液检测(总共1376份精液样本)。我们计算了精子活力、总精子数和总活动精子数。我们根据2021年世界卫生组织(WHO)定义的低精液质量阈值评估结果。女性参与者在长达12个周期或直到受孕的两个月的随访问卷中报告她们的怀孕状况,以先到者为准。我们使用比例概率回归模型来估计受孕率(FRs)和95%置信区间(ci),并对潜在的混杂因素进行调整。结果:经生命表法筛选后,80.7%的夫妇在12个周期内受孕。低精液量组(≤1.5 vs. >.5 mL)的FRs为1.48 (95% CI, 1.05-2.08),低精子浓度组(≤16 vs. > 1600万/mL)的FRs为0.74 (95% CI, 0.56-0.97),低精子活力组(≤42 vs. >42%)的FRs为0.98 (95% CI, 0.81-1.19),低总精子数量组(≤39 vs. > 3900万)的FRs为0.58 (95% CI, 0.38-0.88),低总精子数量组(≤21 vs. > 2100万)的FRs为0.73 (95% CI, 0.52-1.04)。讨论:在北美夫妇的前瞻性孕前队列研究中,大多数基于世卫组织标准的次优精液参数与生育能力降低有关,但精液量低除外。结论:精液质量低于理想水平可能对生育能力产生不利影响。
{"title":"A prospective study of semen quality and fecundability among North American couples planning pregnancy","authors":"Sharonda M. Lovett,&nbsp;Greg J. Sommer,&nbsp;Dmitrii Krivorotko,&nbsp;Amelia K. Wesselink,&nbsp;Kenneth J. Rothman,&nbsp;Elizabeth E. Hatch,&nbsp;Michael L. Eisenberg,&nbsp;Lauren A. Wise","doi":"10.1111/andr.70084","DOIUrl":"10.1111/andr.70084","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Background&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Few studies have prospectively evaluated semen quality (using the most up-to-date clinically relevant definitions) and fecundability (the per-cycle probability of conception).&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Objective&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;To study semen quality in relation to fecundability.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Materials and methods&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;We analyzed prospectively collected data from 763 male participants aged ≥21 years from Pregnancy Study Online (PRESTO), a North American preconception cohort study (2015–2024). Eligible participants for the semen testing substudy resided in the contiguous United States, had been attempting conception for ≤6 cycles at cohort entry, and had a female partner aged 21–45 years with regular menses. Participants used an at-home semen testing device to measure semen volume, sperm concentration, and motile sperm concentration. Participants contributed up to two semen tests during the preconception period (1376 total semen samples). We calculated sperm motility, total sperm count, and total motile sperm count. We evaluated results according to 2021 World Health Organization (WHO)-defined thresholds for low semen quality. Female participants reported their pregnancy status on bimonthly follow-up questionnaires for up to 12 cycles or until conception, whichever came first. We used proportional probabilities regression models to estimate fecundability ratios (FRs) and 95% confidence intervals (CIs), adjusting for potential confounders.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Results&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;After accounting for censoring using life-table methods, 80.7% of couples conceived within 12 cycles. FRs were 1.48 (95% CI, 1.05–2.08) for low semen volume (≤1.5 vs. &gt;1.5 mL), 0.74 (95% CI, 0.56–0.97) for low sperm concentration (≤16 vs. &gt;16 million/mL), 0.98 (95% CI, 0.81–1.19) for low sperm motility (≤42 vs. &gt;42%), 0.58 (95% CI, 0.38–0.88) for low total sperm count (≤39 vs. &gt;39 million), and 0.73 (95% CI, 0.52–1.04) for low total motile sperm count (≤21 vs. &gt;21 million). Associations between low total motile sperm count and fecundability were stronger among couples with &lt;3 cycles of attempt time at cohort entry.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Discussion&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;In this prospective preconception cohort study of North American couples, most suboptimal semen parameters based on WHO criteria were associated with reduced fecundability, with the exception of low semen volume.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Conclusion&lt;/h3&gt;\u0000 \u0000 &lt;p","PeriodicalId":7898,"journal":{"name":"Andrology","volume":"14 1","pages":"184-195"},"PeriodicalIF":3.4,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144615796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Andrology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1